Insider Transactions in Q2 2022 at Cyclacel Pharmaceuticals, Inc. (CYCC)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Sam L Barker Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+45.18%
|
-
|
|
Jun 14
2022
|
Christopher S Henney Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+46.51%
|
-
|
|
Jun 14
2022
|
Brian Schwartz Interim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+44.94%
|
-
|
|
Jun 14
2022
|
Lloyd Sems Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+46.51%
|
-
|
|
Jun 14
2022
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+46.51%
|
-
|
|
Jun 14
2022
|
Karin L Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,822
+44.94%
|
-
|
|
Jun 14
2022
|
Kenneth M. Ferguson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,733
+50.0%
|
-
|